Global CRISPR-Based Therapeutics Market Growth (Status and Outlook) 2025-2031

According to this study, the global CRISPR-Based Therapeutics market size will reach US$ million by 2031.

CRISPR‐based genome editing technology has become an important potential therapeutic tool for various diseases.

United States market for CRISPR-Based Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for CRISPR-Based Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for CRISPR-Based Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key CRISPR-Based Therapeutics players cover Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “CRISPR-Based Therapeutics Industry Forecast” looks at past sales and reviews total world CRISPR-Based Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected CRISPR-Based Therapeutics sales for 2025 through 2031. With CRISPR-Based Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRISPR-Based Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global CRISPR-Based Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRISPR-Based Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CRISPR-Based Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRISPR-Based Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRISPR-Based Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR-Based Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering

Segmentation by Application:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon

Please note: The report will take approximately 2 business days to prepare and deliver. Show more